Low doses of transdermal fentanyl in opioid-naive patients with cancer pain

By Mercadante Sebastiano   Porzio Gianpiero   Ferrera Patrizia   Aielli Federica   Adile Claudio   Ficorella Corrado  

Current Medical Research and Opinion, Vol. 26, Iss. 12, 2010-12 ,pp. : 2765-2768

Informa Healthcare

Access to resources Recommend Favorite

A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain

By Katz Nathaniel   Rauck Richard   Ahdieh Harry   Ma Tina   Gerritsen van der Hoop Roland   Kerwin Rosemary   Podolsky Gilbert  

Current Medical Research and Opinion, Vol. 23, Iss. 1, 2007-01 ,pp. : 117-128

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancer

By Vissers Debby   Stam Wiro   Nolte Thomas   Lenre Malin   Jansen Jeroen  

Current Medical Research and Opinion, Vol. 26, Iss. 5, 2010-05 ,pp. : 1037-1045

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain

By Clark A.J.   Ahmedzai S.H.   Allan L.G.   Camacho F.   Horbay G.L.A.   Richarz U.   Simpson K.  

Current Medical Research and Opinion, Vol. 20, Iss. 9, 2004-09 ,pp. : 1419-1428

Informa Healthcare

Access to resources Recommend Favorite

Sublingual fentanyl orally disintegrating tablet in daily practice: efficacy, safety and tolerability in patients with breakthrough cancer pain

By ÜÜberall Michael A.   Müüller-Schwefe Gerhard H.H.  

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1385-1394

Informa Healthcare

Access to resources Recommend Favorite